In this module, expert faculty present research on the safety, efficacy, and mechanisms of action of emerging therapies for the treatment of atopic dermatitis, including how to integrate the pathophysiology of AD into the selection of treatments. Learners will have the opportunity to gain a better understanding on how AD affects quality of life as patients share their perspectives.
This activity is accredited for 1.0 AMA PRA Category 1 Credits™. It will take approximately 60 minutes to complete the module including the pre/post-test and evaluation. You will receive rationale for the post-test questions as a learning tool.
Take this Course